Landos Biopharma, Inc.
NASDAQ:LABP
22.93 (USD) • At close May 23, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2019 Q4 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||||||||
Current Assets: | ||||||||||||||||
Cash & Cash Equivalents
| 29.054 | 37.549 | 42.408 | 44.049 | 45.244 | 36.64 | 28.88 | 19.241 | 11.288 | 8.305 | 17.893 | 18.687 | 8.572 | 2.416 | 2.477 | 9.808 |
Short Term Investments
| 0 | 0 | 0.062 | 0.687 | 4.762 | 7.762 | 19.111 | 36.51 | 62.508 | 82.575 | 84.777 | 96.44 | 97.786 | 25.718 | 32.854 | 40.157 |
Cash and Short Term Investments
| 29.054 | 37.549 | 42.47 | 44.736 | 50.006 | 44.402 | 47.991 | 55.751 | 73.796 | 90.88 | 102.67 | 115.127 | 106.358 | 28.134 | 35.331 | 49.965 |
Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.003 | 0.002 | 0.001 | 0.154 | 0.113 | 0.001 |
Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.398 | 0 | 0 |
Other Current Assets
| 0.842 | 0.491 | 0.71 | 1.549 | 1.178 | 0.851 | 1.497 | 2.287 | 3.563 | 1.266 | 1.645 | 2.598 | 3.386 | 0.202 | 0.133 | 0.144 |
Total Current Assets
| 29.896 | 38.04 | 43.23 | 46.285 | 51.184 | 45.253 | 49.488 | 58.038 | 77.359 | 92.146 | 104.318 | 117.727 | 109.745 | 29.888 | 35.577 | 50.11 |
Non-Current Assets: | ||||||||||||||||
Property, Plant & Equipment, Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.224 | 0.707 | 0.78 | 0.564 | 0.465 | 0.444 | 0.348 | 0.359 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.027 | 0.026 | 0 | 0 | 0 | 0 | 0.837 | 0.011 |
Total Non-Current Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.251 | 0.733 | 0.78 | 0.564 | 0.465 | 0.444 | 1.185 | 0.37 |
Total Assets
| 29.896 | 38.04 | 43.23 | 46.285 | 51.184 | 45.253 | 49.488 | 58.038 | 77.61 | 92.879 | 105.098 | 118.291 | 110.21 | 30.332 | 36.762 | 50.48 |
Liabilities & Equity: | ||||||||||||||||
Current Liabilities: | ||||||||||||||||
Account Payables
| 1.565 | 1.375 | 1.135 | 1.029 | 2.298 | 3.435 | 3.204 | 4.711 | 9.803 | 12.908 | 10.114 | 10.685 | 8.2 | 8.606 | 6.652 | 2.048 |
Short Term Debt
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.027 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities
| 5.177 | 4.874 | 4.431 | 1.986 | 1.862 | 2.687 | 2.271 | 1.799 | 5.677 | 3.703 | 0.981 | 1.845 | 0.619 | 2.428 | 1.307 | 0.978 |
Total Current Liabilities
| 6.742 | 6.249 | 5.566 | 3.015 | 4.16 | 6.122 | 5.475 | 6.51 | 15.507 | 16.611 | 11.095 | 12.53 | 8.819 | 11.034 | 7.959 | 3.026 |
Non-Current Liabilities: | ||||||||||||||||
Long Term Debt
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 2.298 | 3.435 | 3.204 | 4.711 | 9.83 | 12.908 | 0.085 | 0.149 | 0.212 | 73.313 | 73.037 | 73.037 |
Total Non-Current Liabilities
| 0 | 0 | 0 | 0 | 2.298 | 3.435 | 3.204 | 4.711 | 9.83 | 12.908 | 0.085 | 0.149 | 0.212 | 73.313 | 73.037 | 73.037 |
Total Liabilities
| 6.742 | 6.249 | 5.566 | 3.015 | 4.16 | 6.122 | 5.475 | 6.51 | 15.507 | 16.611 | 11.18 | 12.679 | 9.031 | 84.347 | 80.996 | 76.063 |
Equity: | ||||||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 105.098 | 118.291 | 110.21 | 55.729 | 0 | 0 |
Common Stock
| 0.031 | 0.031 | 0.031 | 0.031 | 0.312 | 0.403 | 0.403 | 0.403 | 0.403 | 0.403 | 0.401 | 0.399 | 0.399 | 0.071 | 0.067 | 0.063 |
Retained Earnings
| -164.259 | -155.362 | -149.243 | -143.383 | -139.461 | -133.427 | -128.195 | -120.299 | -109.015 | -94.151 | -74.054 | -61.45 | -65.547 | -55.729 | -44.388 | -25.585 |
Accumulated Other Comprehensive Income/Loss
| 0 | 0 | -0.001 | -0.007 | 0.079 | -0.057 | -0.211 | -0.392 | -0.467 | -0.225 | 0.131 | -0.142 | -0.102 | 0.01 | 0.036 | -0.077 |
Other Total Stockholders Equity
| 187.382 | 187.122 | 186.877 | 186.629 | 186.094 | 172.212 | 172.016 | 171.816 | 171.182 | 170.241 | 62.342 | 48.514 | 56.219 | -54.096 | 0.051 | 0.016 |
Total Shareholders Equity
| 23.154 | 31.791 | 37.664 | 43.27 | 47.024 | 39.131 | 44.013 | 51.528 | 62.103 | 76.268 | 93.918 | 105.612 | 101.179 | -54.015 | -44.234 | -25.583 |
Total Equity
| 23.154 | 31.791 | 37.664 | 43.27 | 47.024 | 39.131 | 44.013 | 51.528 | 62.103 | 76.268 | 93.918 | 105.612 | 101.179 | -54.015 | -44.234 | -25.583 |
Total Liabilities & Shareholders Equity
| 29.896 | 38.04 | 43.23 | 46.285 | 51.184 | 45.253 | 49.488 | 58.038 | 77.61 | 92.879 | 105.098 | 118.291 | 110.21 | 30.332 | 36.762 | 50.48 |